tradingkey.logo

Inspire Veterinary Partners Inc

IVP

0.708USD

-0.073-9.36%
Market hours ETQuotes delayed by 15 min
3.64MMarket Cap
LossP/E TTM

Inspire Veterinary Partners Inc

0.708

-0.073-9.36%
More Details of Inspire Veterinary Partners Inc Company
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. It specializes in small animal general practice hospitals which serve all manner of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and various other health and wellness offerings.
Company Info
Ticker SymbolIVP
Company nameInspire Veterinary Partners Inc
IPO dateAug 30, 2023
CEOMr. Kimball Carr
Number of employees113
Security typeOrdinary Share
Fiscal year-endAug 30
Address780 Lynnhaven Pkwy #400
CityVIRGINIA BEACH
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code23452
Phone17572883088
Websitehttps://www.inspirevet.com/
Ticker SymbolIVP
IPO dateAug 30, 2023
CEOMr. Kimball Carr
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Lynley Kees
Ms. Lynley Kees
Vice President of Human Resources
Vice President of Human Resources
--
--
Mr. Kevin M. Mcgrath
Mr. Kevin M. Mcgrath
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
-100.00%
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--
Mr. Larry Alexander
Mr. Larry Alexander
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Lynley Kees
Ms. Lynley Kees
Vice President of Human Resources
Vice President of Human Resources
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
9.57%
UBS Financial Services, Inc.
0.56%
Geode Capital Management, L.L.C.
0.47%
Tower Research Capital LLC
0.10%
Other
89.29%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
9.57%
UBS Financial Services, Inc.
0.56%
Geode Capital Management, L.L.C.
0.47%
Tower Research Capital LLC
0.10%
Other
89.29%
Shareholder Types
Shareholders
Proportion
Hedge Fund
9.67%
Investment Advisor
0.57%
Investment Advisor/Hedge Fund
0.48%
Other
89.28%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
36
227.34K
10.73%
+188.01K
2025Q1
37
233.23K
11.15%
+199.50K
2024Q4
35
26.63K
1.96%
+14.11K
2024Q3
29
12.19K
10.24%
+9.83K
2024Q2
26
1.53K
5.46%
+829.00
2024Q1
24
680.00
3.62%
+167.00
2023Q4
22
514.00
27.03%
+264.00
2023Q3
15
280.00
16.84%
+280.00
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
202.90K
9.57%
+202.90K
--
Mar 31, 2025
UBS Financial Services, Inc.
11.95K
0.56%
+11.38K
+1989.16%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.04K
0.47%
+2.11K
+26.57%
Mar 31, 2025
Tower Research Capital LLC
2.17K
0.1%
+1.52K
+233.74%
Mar 31, 2025
Osaic Holdings, Inc.
160.00
0.01%
+36.00
+29.03%
Mar 31, 2025
Harbour Investments, Inc
54.00
0%
--
--
Mar 31, 2025
MAI Capital Management, LLC
39.00
0%
--
--
Mar 31, 2025
Keiser (Charles Stith)
10.00
0%
--
--
May 13, 2025
BofA Global Research (US)
11.00
0%
+2.00
+22.22%
Mar 31, 2025
Wells Fargo Advisors
4.00
0%
+4.00
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
Date
Type
Ratio
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
KeyAI